AI Drug Answers Are Reshaping Pharma’s Competitive Battlefield — And Most Brands Aren’t Watching
When a patient types ‘what’s the best GLP-1 for weight loss’ into ChatGPT, the answer they get back is not […]
When a patient types ‘what’s the best GLP-1 for weight loss’ into ChatGPT, the answer they get back is not […]
The FDA didn’t send a warning letter. No patient filed an adverse event report. No journalist called. But somewhere between
A patient asks ChatGPT how much metformin to take. The answer comes back confident, formatted like a clinical protocol, and
Somewhere right now, a patient is asking Perplexity whether their new prescription interacts with ibuprofen. Another is asking ChatGPT how
When a patient types ‘Ozempic vs. Wegovy: which is better for weight loss?’ into ChatGPT, they get an answer in
Every month, tens of millions of patients and physicians type drug safety questions into ChatGPT, Gemini, Perplexity, and Claude. The
When a patient types “is Ozempic safe for people with a history of pancreatitis?” into ChatGPT, the answer they receive
When a patient types ‘can I take metformin with alcohol’ into ChatGPT, they are not browsing WebMD. They expect a
Somewhere between medical affairs, pharmacovigilance, digital marketing, and IT, there is a gap large enough to swallow a drug brand.
Last year, a patient asked ChatGPT whether it was safe to take semaglutide with a sulfonylurea. The model answered confidently.
FDA-approved drug labeling is one of the most carefully negotiated documents in modern medicine. Every word is litigated, every contraindication
A physician in Phoenix opens ChatGPT and types: “What’s the best GLP-1 for weight loss in a patient with type
Sign in or create a free account to read this DrugChatter article